Karma tip IPMN

Özet

Karma tip intraduktal papiller müsinöz neoplazm, pankreas ana kanalını ve yan dal sistemini birlikte tutan, müsin üreten duktal bir neoplazmdır. Ana kanal tutulumu, yalnız yan dal tutulumuna göre ileri displazi veya invaziv tümör açısından daha dikkatli değerlendirme gerektirir. Pankreas protokollü kontrastlı BT, kanal çapı, kistik yan dal kümeleri, kontrastlanan mural nodül ve yayılımı gösterir; küçük kanal bağlantısı MRCP'de daha belirgin olabilir. IPMN'de görüntüleme hastalık yaygınlığını her zaman doğru haritalamayabilir; bu nedenle kanal içi yayılımın değerlendirilmesi önemlidir.

Faz ve pencere

Arteriyel tanısal

Pankreas parankim fazında ana kanal duvarındaki veya kistik yan dal içindeki yumuşak doku çıkıntısının kontrastlanması, mukus tıkacı ve basit sıvıdan ayrılmasına yardım eder.

Portal tanısal

Ana kanalın seyri ve kalibresi, yan dal kistlerinin çok odaklı dağılımı, pankreas atrofisi, karaciğer lezyonları ve peritoneal yayılım birlikte incelenir.

BT bulguları

• Ana pankreatik kanal boyunca segmental ya da yaygın genişleme ve kanal konturunda düzensizlik
• Ana kanala uzanan veya onunla devamlılığı seçilen, birden fazla segmentte kümelenmiş yan dal kistleri.
• Kist duvarında ya da genişlemiş kanal içinde kontrastlanan papiller mural nodül
• IPMN’de aşırı müsin üretimi görülebilir; kontrastlı BT’de ana kanal içinde papiller kitleler ve kanal genişlemesi izlenebilir.
• Pankreas gövde-kuyruk kesiminde atrofi veya kanal kalibresinde ani değişim
• Birden fazla pankreas segmentinde eş zamanlı kistik odaklar ve ana kanal tutulumu
• İleri hastalıkta pankreas dışına uzanım, bölgesel lenf düğümü veya karaciğer metastazı
• Ana kanal tipi bileşen için, başka bir tıkayıcı neden yokken ana pankreatik kanalın >5 mm genişlemesi değerlendirilir; karma tip tanımı ana kanal ve yan dal tutulumunun birlikte bulunmasına dayanır.

Ölçütler ve sınıflamalar

Kyoto 2024 yüksek risk stigması: kontrastlanan mural nodül

≥5 mm

Kyoto 2024 yüksek risk stigması: ana pankreatik kanal çapı

≥10 mm

Kyoto 2024 kaygı verici özellik: ana kanal çapı

5–<10 mm

Duktal dağılıma göre IPMN

Yan dal tipi yalnız yan dalları; ana kanal tipi ana pankreatik kanalı; karma tip ikisini birlikte tutar. Görüntülemede ana kanal ve yan dal tutulumunu ayrı ayrı tarif et.

Kyoto 2024 risk özellikleri

IAP 2017 ölçütlerinde yüksek risk stigmaları; sarılık, ≥5 mm kontrastlanan mural nodül, ≥10 mm ana pankreatik kanal çapı veya sitolojide yüksek dereceli displazi/kanserdir. Fukuoka 2017 ölçütlerinde kaygı verici özellikler arasında akut pankreatit, kist çapı ≥3 cm, kalınlaşmış ve kontrastlanan kist duvarı, ana kanal çapının 5–9 mm olması, distal atrofiyle birlikte ani kanal kalibre değişikliği, lenfadenopati, serum CA 19-9 yüksekliği ve kist büyüme hızının 2 yılda >5 mm olması yer alır. Tek başına BT görünümü histolojik dereceyi belirlemez.

Normalde

Normal pankreasta ana kanal ince, düzgün konturlu ve gövde boyunca izlenebilir; yan dallar belirgin kistik boşluklar oluşturmaz. Aynı anatomik düzeyde kanalın kalibresini, yan dal kistlerinin ana kanalla devamlılığını ve pankreas parankiminin gövde-kuyruk tarafında incelip incelmediğini karşılaştır.

Ayırıcı tanı

Yan dal IPMN

yan dal kistleri vardır, ancak ana kanalda neoplastik tutulum gösteren mural doku veya belirgin kanal değişikliği yoktur.

Müsinöz kistik neoplazm

çoğunlukla gövde-kuyrukta tek kitle oluşturur ve ana kanalla doğrudan bağlantı beklenmez.

Seröz kistik neoplazm

IPMN'den farklı olarak ana kanalla bağlantılı müsin üretimli papiller tutulum göstermez.

Pankreatik psödokist

pankreatit öyküsü ve çevresel inflamasyon eşlik edebilir; papiller kontrastlanan mural doku ve kanal kaynaklı çok odaklı patern beklenmez.

Pankreatik duktal adenokarsinom

fokal infiltratif hipoenhans kitle, ani kanal kesilmesi ve distal atrofi ön plandadır; yaygın kistik yan dal bağlantıları tipik değildir.

Tuzaklar

• IPMN’de ana kanal segmental veya yaygın genişleyebilir; karma tip dağılımı tarif ederken ana kanal ve yan dal tutulumunu birlikte değerlendir.
• İnce yan dal bağlantısı rutin aksiyel BT'de görünmeyebilir; negatif BT bağlantıyı dışlamaz, şüphede MRCP ile kanal ağacı daha iyi haritalanır.
• Bağımlı mukus veya debris mural nodülü taklit edebilir; kontrast sonrası gerçek nodülde iç kontrastlanma aranır, BT belirsizse MR ya da EUS korelasyonu gerekir.
• Ana pankreatik kanal genişlemesi kronik pankreatitte de görülebileceğinden, başka bir tıkayıcı neden dışlanmadan genişleme ana kanal tipi IPMN bileşeni olarak sınıflandırılmamalıdır.

Kendini dene

1. BT’de ana kanal içinde kontrastlanan papiller dokuya ek olarak ana kanalla iletişimli yan dal kistleri görülüyor. Hangi dağılım tipi vardır?

   • Karma tip IPMN
   • Müsinöz kistik neoplazm
   • Seröz kistik neoplazm
   • Pankreatik psödokist
   Cevabı göster

   Karma tip IPMN. Ana kanal ve yan dal sisteminin birlikte tutulması karma tip IPMN tanımına uyar.

2. Pankreatit öyküsü olmayan hastada kanal boyunca kist kümeleri ve iç kontrastlanan odak görülüyor. Odak neyi düşündürür?

   • Mural neoplastik nodül
   • Mukus tıkacı
   • Psödokist debris'i
   • Seröz kist septası
   Cevabı göster

   Mural neoplastik nodül. Kontrastlanan papiller yumuşak doku mural neoplastik nodül lehinedir. Mukus ve debris genellikle kontrastlanmaz; seröz kist septaları ise ana kanal içindeki papiller çıkıntı görünümünü açıklamaz.

İlgili konular

• Pankreatik psödokist
• Pankreas metastazı

Kaynaklar

Bu sayfadaki 48 cümle ve 2 quiz sorusu aşağıdaki kaynaklardan alıntılarla otomatik olarak karşılaştırıldı; 8 cümle bu karşılaştırmada düzeltildi (2026-10-09).

1. Fistula formation into other organs secondary to intraductal papillary mucinous neoplasm of the pancreas: A case report and literature reviewpmc.ncbi.nlm.nih.gov
2. Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and managementpmc.ncbi.nlm.nih.gov
3. Main- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical Resectionpmc.ncbi.nlm.nih.gov
4. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature reviewpmc.ncbi.nlm.nih.gov
5. Surgical Intervention and Prognosis of Intraductal Papillary Mucinous Adenoma in Elderly Patients: A Single Center Retrospective Studypmc.ncbi.nlm.nih.gov
6. Main- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical Resection.pubmed.ncbi.nlm.nih.gov
7. [Resection of main duct and mixed type IPMN ≥5 mm].pubmed.ncbi.nlm.nih.gov
8. [Cystic lesions of the pancreas : Differential diagnostics and treatment].pubmed.ncbi.nlm.nih.gov
9. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review.pubmed.ncbi.nlm.nih.gov
10. Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management.pubmed.ncbi.nlm.nih.gov
11. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?pubmed.ncbi.nlm.nih.gov
12. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection.pubmed.ncbi.nlm.nih.gov
13. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.pubmed.ncbi.nlm.nih.gov
14. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.pubmed.ncbi.nlm.nih.gov
15. Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.pubmed.ncbi.nlm.nih.gov
16. Pancreatic intraductal papillary mucinous neoplasm associated colloid carcinoma.pubmed.ncbi.nlm.nih.gov
17. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.pubmed.ncbi.nlm.nih.gov
18. Main-duct Intraductal Papillary Mucinous Neoplasm: High Cancer Risk in Duct Diameter of 5 to 9 mm.pubmed.ncbi.nlm.nih.gov
19. Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas.pubmed.ncbi.nlm.nih.gov
20. Undifferentiated carcinoma of the pancreas arising from intraductal papillary mucinous neoplasm: a case report.pubmed.ncbi.nlm.nih.gov
21. Risk Assessment of Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm Harboring Multiple Worrisome Features and High-Risk Stigmata: A Single-Center Cohort Study.pubmed.ncbi.nlm.nih.gov
22. Malignant potential of intraductal papillary mucinous neoplasm (IPMN) of the pancreas: imaging assessment of IPMN-derived cancer and concomitant pancreatic ductal adenocarcinoma.pubmed.ncbi.nlm.nih.gov
23. Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future.pubmed.ncbi.nlm.nih.gov
24. DIAGNOSIS AND MANAGEMENT OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS: A NARRATIVE REVIEW BASED ON INTERNATIONAL GUIDELINES.pubmed.ncbi.nlm.nih.gov
25. Common cystic pancreatic neoplasms: A comprehensive magnetic resonance imaging-based review of typical and atypical imaging features.pubmed.ncbi.nlm.nih.gov
26. Feasibility of Peroral Pancreatoscopy Using the 9-Fr eyeMAX for Surgical Planning in Main-Duct and Mixed-Type Intraductal Papillary Mucinous Neoplasms.pubmed.ncbi.nlm.nih.gov
27. Postoperative Outcomes and Strategic Refinement in Intraductal Papillary Mucinous Neoplasm Management: A Single Academic Cancer Center Experience.pubmed.ncbi.nlm.nih.gov
28. Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for pancreaticobiliary cytopathology in solid pancreatic lesions.pubmed.ncbi.nlm.nih.gov
29. Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment.pubmed.ncbi.nlm.nih.gov
30. Oncocytic intraductal papillary neoplasm of the pancreas: Multimodality imaging and cytopathologic correlation.pubmed.ncbi.nlm.nih.gov
31. Letter to the Editor: De-escalation of branch duct intraductal papillary mucinous neoplasms surveillance.pubmed.ncbi.nlm.nih.gov
32. Differentiation of intraductal papillary mucinous neoplasms and pancreatic ductal adenocarcinoma using arterial-phase CT radiomics combined with clinical features.pubmed.ncbi.nlm.nih.gov
33. Pancreatic intraductal papillary mucinous neoplasm with invasive carcinoma and uterine metastasis: a case report.pubmed.ncbi.nlm.nih.gov
34. Role of Endoscopic Ultrasonography in Management of Pancreaticobiliary Cancers: Recent Trends and Advances.pubmed.ncbi.nlm.nih.gov
35. Surgical Strategies for Tumors of the Pancreas and Duodenum.pubmed.ncbi.nlm.nih.gov
36. Peroral Pancreatoscopy for Differentiating Main Duct IPMN from Chronic Pancreatitis: A Narrative Review and a Case Series.pubmed.ncbi.nlm.nih.gov
37. Pancreatic Cystic Lesions: From Basic Knowledge to Recent Guidelines.pubmed.ncbi.nlm.nih.gov
38. CT and MRI findings of intraductal tubulopapillary neoplasm of the pancreas.pubmed.ncbi.nlm.nih.gov
39. Advances for Managing Pancreatic Cystic Lesions: Integrating Imaging and AI Innovations.pubmed.ncbi.nlm.nih.gov
40. Risk Assessment and Radiomics Analysis in Magnetic Resonance Imaging of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN).pubmed.ncbi.nlm.nih.gov
41. Intraductal papillary neoplasm of the biliary tract with typical clinicopathological, endoscopic features: A case report.pubmed.ncbi.nlm.nih.gov
42. Ectopic β-hCG-Expressing Hepatic Neoplasm with Cutaneous Metastasis in a Young Postpartum Woman: A Case Report and Literature Review.pubmed.ncbi.nlm.nih.gov
43. Synchronous Multifocal Intraductal Tubulopapillary Neoplasm of the Pancreas Treated with Total Pancreatectomy: A Case Report.pubmed.ncbi.nlm.nih.gov
44. Australian Pancreatic Cyst Registry: protocol for a prospective national clinical quality registry of intraductal papillary mucinous neoplasms.pubmed.ncbi.nlm.nih.gov
45. Intraductal papillary mucinous neoplasm unveiling incidental multifocal pancreatic neuroendocrine tumors: a challenging case report.pubmed.ncbi.nlm.nih.gov
46. Rapidly Progressive Neuroendocrine Carcinoma of the Ampulla of Vater Detected During Intraductal Papillary Mucinous Neoplasm Surveillance.pubmed.ncbi.nlm.nih.gov
47. Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis.pubmed.ncbi.nlm.nih.gov
48. Endoscopic-guided chemoablation of an inoperable main-duct intraductal papillary mucinous neoplasm.pubmed.ncbi.nlm.nih.gov
49. Discordant pathology following pancreatoduodenectomy for suspected intraductal papillary mucinous neoplasm: reassessment of cyst fluid genetic analysis.pubmed.ncbi.nlm.nih.gov
50. Recent Advances in Non-Invasive Blood Markers for Intraductal Papillary Mucinous Neoplasm Grading.pubmed.ncbi.nlm.nih.gov
51. Pancreaticobiliary Fistula Caused by Intraductal Papillary Mucinous Adenoma Requiring Pancreaticoduodenectomy.pubmed.ncbi.nlm.nih.gov
52. Videolaparoscopic pancreatojejunostomy using a hybrid technique in chronic pancreatitis without significant ductal dilatation.pubmed.ncbi.nlm.nih.gov
53. Acute Emergent Biliary Pathologies Identified Using Point-of-Care Ultrasound.pubmed.ncbi.nlm.nih.gov
54. Endoscopic Management of Obstructive Chronic Pancreatitis in a Dual Solid Organ Transplant Recipient: A Case Report.pubmed.ncbi.nlm.nih.gov
55. Portuguese Pancreatic Club Perspective on Intraductal Papillary Mucinous Neoplasm Diagnosis, Characterization and Indications for Fine-Needle Aspiration/Biopsy, Advanced Endoscopic Ultrasound Imaging Techniques and Role of Pancreatoscopy.pubmed.ncbi.nlm.nih.gov
56. Mixed exocrine-neuroendocrine intraductal papillary mucinous neoplasms of the pancreas: a case series.pubmed.ncbi.nlm.nih.gov
57. Punctate Palmoplantar Keratoderma Type 1 (PPPK1) Associated with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN): A Case Report.pubmed.ncbi.nlm.nih.gov
58. Beware of Radiological Diagnosis of Pancreatic Pseudocyst: Lesson Learned From an Interesting Case.pubmed.ncbi.nlm.nih.gov
59. Beyond the Expected: A Case-Based Exploration and Literature Review on the Rare Evolution of Pseudomyxoma Peritonei From a Side-Branch Intraductal Papillary Mucinous Neoplasm.pubmed.ncbi.nlm.nih.gov
60. Incidental cystic pancreatic neuroendocrine neoplasm and differential diagnosis.pubmed.ncbi.nlm.nih.gov
61. Beyond the Six-Week Rule: Contemporary Insights Into Pancreatic Pseudocyst.pubmed.ncbi.nlm.nih.gov
62. Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer.pubmed.ncbi.nlm.nih.gov
63. Real-time guidance of lauromacrogol ablation for pancreatic cystic lesions using confocal laser endomicroscopy.pubmed.ncbi.nlm.nih.gov
64. From bench to bedside: pancreatic juice as a platform for biomarker discovery in pancreatic disease.pubmed.ncbi.nlm.nih.gov
65. Fistulating Intraductal Papillary Mucinous Neoplasms (IPMNs): Case Series and Discussion of a Rare Complication.pubmed.ncbi.nlm.nih.gov
66. Can abbreviated MRI replace standard protocols in IPMN surveillance? A retrospective comparative study.pubmed.ncbi.nlm.nih.gov
67. Non-contrast MRI features of mucin plugs and mural nodules in pancreatic cystic lesions.pubmed.ncbi.nlm.nih.gov
68. Correlation of pathological types and imaging features in pancreatic cancer.pubmed.ncbi.nlm.nih.gov
69. Pancreatic Cyst Management: A Multimodal and Interdisciplinary Approach.pubmed.ncbi.nlm.nih.gov
70. Feasibility of deep learning-accelerated HASTE-FS for pancreatic cystic lesion surveillance: comparison with conventional HASTE and MRCP.pubmed.ncbi.nlm.nih.gov
71. Pancreatic ductal adenocarcinoma staging: a narrative review of radiologic techniques and advances.pubmed.ncbi.nlm.nih.gov
72. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations.pubmed.ncbi.nlm.nih.gov
73. Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens.pubmed.ncbi.nlm.nih.gov
74. A Rare Pediatric Intraductal Papillary Mucinous Neoplasm Presenting as a Pancreatic Pseudocyst With Splenic Vein Thrombosis and Gastric Variceal Hemorrhage.pubmed.ncbi.nlm.nih.gov
75. Rethinking imaging-based IPMN subtype classification: is mixed-type a necessary radiologic category?pubmed.ncbi.nlm.nih.gov
76. Case Report: Metachronous oncocytic and colloid carcinoma arising from pancreatic intraductal neoplasms over four decades.pubmed.ncbi.nlm.nih.gov
77. Positron Emission Tomography (PET) in Oncology.pubmed.ncbi.nlm.nih.gov
78. Commentary: an eye on PET quantification.pubmed.ncbi.nlm.nih.gov
79. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic neoplasms: a comprehensive review.pubmed.ncbi.nlm.nih.gov
80. Spectral attenuation curves of photon-counting detector CT scans for the differentiation between mucinous and non-mucinous cyst fluids of pancreatic lesions - a proof-of-concept study.pubmed.ncbi.nlm.nih.gov
81. CT-Derived Radiomic Signature of MUC6 Expression Improves Guideline-Based Risk Stratification in Intraductal Papillary Mucinous Neoplasms.pubmed.ncbi.nlm.nih.gov
82. Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA): Are We Getting Evidence-Based Results? A Systematic Review According to the Levels of Evidence.pubmed.ncbi.nlm.nih.gov
83. Role of pancreatoscopy in the management of suspected and confirmed intraductal papillary mucinous neoplasm of the pancreas.pubmed.ncbi.nlm.nih.gov
84. Applications and Prospects of Artificial Intelligence-Assisted Endoscopic Ultrasound in Digestive System Diseases.pubmed.ncbi.nlm.nih.gov
85. Special Issue: EACR 2026 Congress: Innovative Cancer Science, 8-11 June 2026.pubmed.ncbi.nlm.nih.gov
86. EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025.pubmed.ncbi.nlm.nih.gov
87. Solid Pseudopapillary Neoplasm With Extensive Intratumoral Hemorrhage.pubmed.ncbi.nlm.nih.gov
88. Diagnostic Method Advancement to Improve the Prognosis of Pancreatic Ductal Adenocarcinoma.pubmed.ncbi.nlm.nih.gov
89. A 30-year institutional experience of insulinoma management at a tertiary care center: a case series.pubmed.ncbi.nlm.nih.gov
90. Schwannoma Likely Arising from the Pancreatic Head Nerve Plexus That Mimicked a Mucinous Cystic Neoplasm and Was Treated by Pancreaticoduodenectomy: A Case Report.pubmed.ncbi.nlm.nih.gov
91. GerPaCyst - The trial protocol of the prospective, multicenter, interdisciplinary German Pancreas Club Cyst Registry.pubmed.ncbi.nlm.nih.gov
92. 불분명한 소아 복부 종괴: 영상 기반 진단 접근법.pubmed.ncbi.nlm.nih.gov
93. Pancreatic Cancer Detection in Intraductal Papillary Mucinous Neoplasm (IPMN)-New Insights.pubmed.ncbi.nlm.nih.gov
94. Cancer Risk After Initial Surveillance of Intraductal Papillary Mucinous Neoplasms (IPMNs): Are We Missing the Window for Prevention?pubmed.ncbi.nlm.nih.gov
95. Small and Stable Pancreatic Cysts Are Reassuring During Surveillance: Results From the PACYFIC Trial.pubmed.ncbi.nlm.nih.gov
96. Interobserver agreement in dysplasia grading of intraductal papillary mucinous neoplasms: performance of Kyoto guidelines and optimization of endomicroscopy biomarkers through pathology reclassification.pubmed.ncbi.nlm.nih.gov
97. A modified stent-free Chen's U-suture technique in pediatric pancreaticojejunostomy: safety and efficacy.pubmed.ncbi.nlm.nih.gov
98. Pancreatic Atrophy: A Narrative Review and Surgical Interpretation.pubmed.ncbi.nlm.nih.gov
99. A case of intraductal oncocytic papillary neoplasm treated with distal pancreatectomy.pubmed.ncbi.nlm.nih.gov
100. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs.pubmed.ncbi.nlm.nih.gov
101. Pancreatic tail cancer in the setting of pancreatitis with a review of the literature: A case report.pubmed.ncbi.nlm.nih.gov
102. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments.pubmed.ncbi.nlm.nih.gov
103. Endoscopic ultrasound for pancreatic cystic lesions: a narrative review.pubmed.ncbi.nlm.nih.gov
104. Portuguese Pancreatic Club Perspective on Epidemiology, Classification, and Natural History of Pancreatic Intraductal Papillary Mucinous Neoplasms.pubmed.ncbi.nlm.nih.gov
105. Contrast-Enhanced Harmonic Endoscopic Ultrasonography for Prediction of Aggressiveness and Treatment Response in Patients with Pancreatic Lesions.pubmed.ncbi.nlm.nih.gov
106. Monitoring of low-risk pancreatic cystic lesions with targeted abdominal ultrasound: diagnostic yield, clinical utility, and acceptance.pubmed.ncbi.nlm.nih.gov
107. Spatial Analysis of Intraductal Papillary Mucinous Neoplasms Defines a Paradoxical Keratin 17-Positive, Low-Grade Epithelial Population Harboring Malignant Features.pubmed.ncbi.nlm.nih.gov
108. Current Considerations in Nonoperative Surveillance of Intraductal Papillary Mucinous Neoplasms.pubmed.ncbi.nlm.nih.gov
109. How to distinguish pancreatic tumors and assess the necessity for biopsy.pubmed.ncbi.nlm.nih.gov
110. Approach to Cystic Lesions of the Pancreas: Review of Literature.pubmed.ncbi.nlm.nih.gov
111. Use of an Algo-Based Decision-Making Tool to Compare Real-Life Clinical Practice in a Single Tertiary Center with the Kyoto IPMN Surveillance Recommendations.pubmed.ncbi.nlm.nih.gov
112. Sequential Pancreatic Ascites and Hemosuccus Pancreaticus from an Identical Rupture Site in Branch-Duct Intraductal Papillary Mucinous Neoplasm: A Case Report.pubmed.ncbi.nlm.nih.gov
113. Endoscopic ultrasound-guided radiofrequency ablation for large branch-duct intraductal papillary mucinous neoplasms: Safety and efficacy trial.pubmed.ncbi.nlm.nih.gov
114. Diagnostic and therapeutic guidelines for pancreatic cystic tumors: recommendations of Polish Pancreatic Club experts.pubmed.ncbi.nlm.nih.gov
115. Pancreatic Cystic Lesions in the Older Patient: A Review of Clinical Guidelines and Management.pubmed.ncbi.nlm.nih.gov

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez, tıbbi tavsiye değildir. Metinler yapay zekâ desteğiyle yazıldı ve otomatik bir adımda kaynak alıntılarıyla karşılaştırıldı; bu bir tıbbi doğrulama değildir ve içerik uzman radyolog incelemesinden geçmedi. Klinik kararlarda güncel kılavuzları, kurum protokollerini ve radyoloji raporunu esas alın.